VolitionRx (NYSEAMERICAN:VNRX – Get Free Report) is anticipated to issue its quarterly earnings data before the market opens on Monday, March 24th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $0.55 million for the quarter.
VolitionRx Stock Down 3.6 %
VNRX opened at $0.56 on Monday. The stock has a market capitalization of $35.45 million, a PE ratio of -1.00 and a beta of 1.59. VolitionRx has a 1 year low of $0.43 and a 1 year high of $1.02.
VolitionRx Company Profile
Further Reading
- Five stocks we like better than VolitionRx
- Investing in Commodities: What Are They? How to Invest in Them
- How to Build the Ultimate Everything ETF Portfolio
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for VolitionRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRx and related companies with MarketBeat.com's FREE daily email newsletter.